132 related articles for article (PubMed ID: 12634969)
21. 11C-Metomidate PET/CT Detected Multiple Ectopic Adrenal Rest Tumors in a Woman With Congenital Adrenal Hyperplasia.
Burman P; Falhammar H; Waldenström E; Sundin A; Bitzén U
J Clin Endocrinol Metab; 2021 Jan; 106(2):e675-e679. PubMed ID: 33245336
[TBL] [Abstract][Full Text] [Related]
22. Evaluation of head and neck cancer with 18F-FDG PET: a comparison with conventional methods.
Kresnik E; Mikosch P; Gallowitsch HJ; Kogler D; Wiesser S; Heinisch M; Unterweger O; Raunik W; Kumnig G; Gomez I; Grünbacher G; Lind P
Eur J Nucl Med; 2001 Jul; 28(7):816-21. PubMed ID: 11504077
[TBL] [Abstract][Full Text] [Related]
23. First-in-human evaluation of [
Silins I; Sundin A; Lubberink M; O'Sullivan L; Gurnell M; Aigbirhio F; Brown M; Wall A; Åkerström T; Roslin S; Hellman P; Antoni G
Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):398-409. PubMed ID: 36074157
[TBL] [Abstract][Full Text] [Related]
24. Comparison of whole-body PET/CT and PET/MRI in breast cancer patients: lesion detection and quantitation of 18F-deoxyglucose uptake in lesions and in normal organ tissues.
Pace L; Nicolai E; Luongo A; Aiello M; Catalano OA; Soricelli A; Salvatore M
Eur J Radiol; 2014 Feb; 83(2):289-96. PubMed ID: 24331845
[TBL] [Abstract][Full Text] [Related]
25. Imaging of adrenocortical metastases with [11C]metomidate.
Mitterhauser M; Dobrozemsky G; Zettinig G; Wadsak W; Vierhapper H; Dudczak R; Kletter K
Eur J Nucl Med Mol Imaging; 2006 Aug; 33(8):974. PubMed ID: 16721573
[No Abstract] [Full Text] [Related]
26. A concomitant false-negative ¹⁸F-FDG PET imaging in an adrenocortical carcinoma and a high uptake in a corresponding liver metastasis.
Ghander C; Tissier F; Tenenbaum F; Silvera S; Ragazzon B; Bertherat J; Bertagna X; Dousset B; Richard B; Legmann P; Groussin L
J Clin Endocrinol Metab; 2012 Apr; 97(4):1096-7. PubMed ID: 22319030
[No Abstract] [Full Text] [Related]
27. Functional imaging of adrenal cortex.
Prado-Wohlwend S;
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2020; 39(6):393-404. PubMed ID: 33222841
[TBL] [Abstract][Full Text] [Related]
28. Imaging of gynecologic tumors: comparison of (11)C-choline PET with (18)F-FDG PET.
Torizuka T; Kanno T; Futatsubashi M; Okada H; Yoshikawa E; Nakamura F; Takekuma M; Maeda M; Ouchi Y
J Nucl Med; 2003 Jul; 44(7):1051-6. PubMed ID: 12843219
[TBL] [Abstract][Full Text] [Related]
29. 11C-metomidate positron emission tomography after dexamethasone suppression for detection of small adrenocortical adenomas in primary aldosteronism.
Hennings J; Sundin A; Hägg A; Hellman P
Langenbecks Arch Surg; 2010 Sep; 395(7):963-7. PubMed ID: 20644954
[TBL] [Abstract][Full Text] [Related]
30.
Chen Cardenas SM; Santhanam P
Endocrine; 2020 Dec; 70(3):479-487. PubMed ID: 32886316
[TBL] [Abstract][Full Text] [Related]
31. Molecular Imaging in the Management of Adrenocortical Cancer: A Systematic Review.
Wong KK; Miller BS; Viglianti BL; Dwamena BA; Gauger PG; Cook GJ; Colletti PM; Rubello D; Gross MD
Clin Nucl Med; 2016 Aug; 41(8):e368-82. PubMed ID: 26825212
[TBL] [Abstract][Full Text] [Related]
32. Amino acid uptake in the skeletal muscle measured using [11C]methylaminoisobutyrate (MEAIB) and PET.
Asola MR; Virtanen KA; Peltoniemi P; Någren K; Yu M; Mattila K; Jyrkkiö S; Metsärinne K; Nuutila P; Knuuti J
Eur J Nucl Med Mol Imaging; 2002 Nov; 29(11):1485-91. PubMed ID: 12397468
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic and prognostic value of 18-fluorodeoxyglucose positron emission tomography in adrenocortical carcinoma: a prospective comparison with computed tomography.
Leboulleux S; Dromain C; Bonniaud G; Aupérin A; Caillou B; Lumbroso J; Sigal R; Baudin E; Schlumberger M
J Clin Endocrinol Metab; 2006 Mar; 91(3):920-5. PubMed ID: 16368753
[TBL] [Abstract][Full Text] [Related]
34. Adrenal lesions: characterization with fused PET/CT image in patients with proved or suspected malignancy--initial experience.
Blake MA; Slattery JM; Kalra MK; Halpern EF; Fischman AJ; Mueller PR; Boland GW
Radiology; 2006 Mar; 238(3):970-7. PubMed ID: 16505394
[TBL] [Abstract][Full Text] [Related]
35. [Methyl-11C]thymidine positron emission tomography in tumoral and non-tumoral cerebral lesions.
De Reuck J; Santens P; Goethals P; Strijckmans K; Lemahieu I; Boon P; Achten E; Lemmerling M; Vandekerckhove T; Caemaert J
Acta Neurol Belg; 1999 Jun; 99(2):118-25. PubMed ID: 10427354
[TBL] [Abstract][Full Text] [Related]
36. Comparison of three different purification methods for the routine preparation of [11C] Metomidate.
Mitterhauser M; Wadsak W; Langer O; Schmaljohann J; Zettinig G; Dudczak R; Viernstein H; Kletter K
Appl Radiat Isot; 2003; 59(2-3):125-8. PubMed ID: 12941500
[TBL] [Abstract][Full Text] [Related]
37. FDG-PET in adrenocortical carcinoma.
Becherer A; Vierhapper H; Pötzi C; Karanikas G; Kurtaran A; Schmaljohann J; Staudenherz A; Dudczak R; Kletter K
Cancer Biother Radiopharm; 2001 Aug; 16(4):289-95. PubMed ID: 11602999
[TBL] [Abstract][Full Text] [Related]
38. Prospective comparison of [18F]fluorodeoxyglucose positron emission tomography with conventional assessment by computed tomography scans and serum tumor markers for the evaluation of residual masses in patients with nonseminomatous germ cell carcinoma.
Kollmannsberger C; Oechsle K; Dohmen BM; Pfannenberg A; Bares R; Claussen CD; Kanz L; Bokemeyer C
Cancer; 2002 May; 94(9):2353-62. PubMed ID: 12015760
[TBL] [Abstract][Full Text] [Related]
39. Misdiagnoses of 11C-choline combined with 18F-FDG PET imaging in brain tumours.
Huang Z; Zuo C; Guan Y; Zhang Z; Liu P; Xue F; Lin X
Nucl Med Commun; 2008 Apr; 29(4):354-8. PubMed ID: 18317300
[TBL] [Abstract][Full Text] [Related]
40. Whole-body PET/CT with 11C-meta-hydroxyephedrine in tumors of the sympathetic nervous system: feasibility study and comparison with 123I-MIBG SPECT/CT.
Franzius C; Hermann K; Weckesser M; Kopka K; Juergens KU; Vormoor J; Schober O
J Nucl Med; 2006 Oct; 47(10):1635-42. PubMed ID: 17015899
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
